Picture of Recordati Industria Chimica e Farmaceutica logo

REC — Recordati Industria Chimica e Farmaceutica News Story

0.000.00%
it flag iconLast trade - 00:00
HealthcareConservativeLarge CapHigh Flyer

Recordati's revenue rises 5% in Q1 despite FX impact

April 29 (Reuters) - Italian pharmaceutical company Recordati RECI.MI reported on Wednesday a 4.9% rise in its first-quarter net revenue to 713.4 million euros ($834.7 million).

The company said its revenue was hit by an adverse impact from foreign exchange (FX) of 29.1 million euros.

Recordati will post its full Q1 financial results on May 12, 2026.

($1 = 0.8547 euros)

 (Reporting by Mirko Miorelli)

 ((Mirko.miorelli@thomsonreuters.com))

Recent news on Recordati Industria Chimica e Farmaceutica

See all news